Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,489-10,500 of 23,847
Drug study icon
CompletedNCT02902081

Cannabidiol and Emotional Stimuli

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
AddictionDrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
United States
Sponsor
University of Chicago
Condition
Addiction
Drug study icon
CompletedNCT03518801

Cannabidiol and Prolonged Exposure

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
PTSDDrugOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Drug study icon
CompletedNCT03248167

Cannabidiol as a Treatment for AUD Comorbid With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In New York
PTSD, AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
PTSD, Addiction
Drug study icon
CompletedNCT05571592

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In New York
AnxietyDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Anxiety
Drug study icon
TerminatedNCT03310593

Cannabidiol as an Adjunctive Treatment for Depression in bipolarity

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Porto Alegre
Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
Bipolarity, Depression
Drug study icon
WithdrawnNCT03904849

Cannabidiol for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
AddictionDrugFrom 21 Years to 40 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
OngoingEUCTR 2019-003623-37

CANnabidiol for Parkinson’s Disease Psychosis

This study is comparing Cannabidiol (CBD) with placebo for people with Parkinson's disease psychosis or Elderly. Participants receive Cannabidiol (CBD) or placebo and complete study visits and assessments.

In United Kingdom
SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.